NIH-funded research Fellowship grant

Investigating how itaconate affects inflammatory blood cell accumulation to prevent anemia

Official title: Itaconate mediated control of inflammatory hemophagocyte accumulation

Funded at University of Washington · NIH-11078658 · Data updated 2026-11-12

This study is looking at how a substance called itaconate, made by an enzyme named IRG1, helps manage certain immune cells that can cause severe anemia, with the goal of finding new ways to treat anemia linked to inflammation.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMarch 16, 2024
Project endJune 15, 2025
Funding year2025
Award (this year)$11,039
NIH project number5F31AI178955-02
Project IDNIH-11078658 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from severe anemia related to chronic inflammatory conditions.

Less likely to help

Patients with anemia not associated with inflammation or those with other unrelated blood disorders may not benefit from this research.

What this research studies

This research explores the role of the enzyme IRG1 and its product, itaconate, in controlling inflammatory blood cells that can lead to severe anemia. By understanding how itaconate influences the behavior of specific immune cells, the study aims to restore the balance between red blood cell production and clearance during inflammation. The research employs mouse models to examine the transition of monocytes into specialized inflammatory hemophagocytes, which are implicated in the development of anemia. This could provide insights into new therapeutic strategies for managing anemia associated with inflammatory conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or alleviate severe anemia in patients with inflammatory diseases.

How similar studies have gone: While the specific mechanisms of itaconate in this context are still being explored, similar approaches targeting inflammatory processes have shown promise in other studies.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Lichauco, Katrina — University of Washington
  • Study coordinator: Lichauco, Katrina

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.